Bloodborne Pathogens. Safety Guidelines

Similar documents
Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management

Exposure. What Healthcare Personnel Need to Know

OCCUPATIONAL HEALTH, DISABILITY AND LEAVE SECTOR MEASURES TO MINIMIZE EXPOSURE TO BLOODBORNE PATHOGENS AND POST-EXPOSURE PROPHYLAXIS POLICY

Managing Bloodborne Pathogens Exposures

Bloodborne Pathogens

FLORENCE TOWNSHIP BOARD OF EDUCATION FILE CODE: / Florence, New Jersey

Bloodborne Pathogens. Updated

DO YOU WORK AROUND BLOOD OR BODY FLUIDS? Cal/OSHA s New Rules

WHY ARE WE HERE? OSHA BB Pathogen standard. The more you know, the better you will perform in real situations!

Leader s Guide E4017. Bloodborne Pathogens: Always Protect Yourself

Bloodborne Pathogens. Scott Anderson CCEMTP. Materials used with permission from the Oklahoma State University

When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII)

AUBURN UNIVERSITY HARRISON SCHOOL OF PHARMACY

12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS

OSHA s Bloodborne Pathogens Standard

Corporate Safety Infection Prevention Employee Health

Roger Williams University. Bloodborne Pathogens Exposure Control Plan

EXPOSURE CONTROL PLAN (sample) 1 Child Care Directors and Employers

Definitions. This plan. membrane, These are. additions and. and. weeping a source of. withstand the. demands of to or from a

POLICY 08:18:00 BLOODBORNE PATHOGENS CONTROL PLAN

HEPATITIS A, B, AND C

Bloodborne Pathogens Program Revised July,

A P P E N D I X SAMPLE FORMS

BLOODBORNE PATHOGENS EXPOSURE CONTROL PROGRAM

BLOODBORNE PATHOGENS IN SCHOOLS

Use and Disposal of Sharps

Synopsis from the ASA Recommendations for Infection Control for the Practice of Anesthesiology (Third Edition, 2011)*

Bloodborne Pathogens (BBPs) Louisiana Delta Community College

Kean University BS Degree Program in Athletic Training BLOOD BORN PATHOGENS POLICY

6.0 Infectious Diseases Policy: Student Exposure Control Plan

Blood borne Pathogens

THE A, B, C S OF HEPATITIS. Matt Eidem, M.D. Digestive Health Associates of Texas 1600 Coit Road Suite #301 Plano, Texas (972)

Attachment D Infection Control Policy METHODS OF IMPLEMENTATION AND CONTROL

University of St. Francis

OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION (OSHA)

JAC-CEN-DEL COMMUNITY SCHOOLS BLOODBORNE PATHOGENS UNIVERSAL PRECAUTIONS A BACK TO SCHOOL TRADITION

Mercyhurst University Athletic Training Program Bloodborne Pathogens Exposure Control Plan

Bloodborne Exposure Incident Report -Questionnaire and Report-

Bloodborne Pathogens Exposure Control Plan

Viral Hepatitis A, B, and C

Guidelines for Managing Exposures to Blood Borne Pathogens

Mock OSHA Inspection:

OCCUPATIONAL EXPOSURE TO BLOODBORNE PATHOGENS (29 CFR )

Bloodborne Pathogens. San Diego Unified School District Nursing & Wellness Program August 2013

Didactic Series. Updated Post-Exposure Prophylaxis (PEP) Guidelines. Daniel Lee, MD UCSD Medical Center, Owen Clinic January 9, 2014

Manual Document Page Issue Date TABLE OF CONTENTS

1) Giving patient access and control over their health information

KEY CAL/OSHA STANDARDS THAT APPLY TO MOST EMPLOYERS

DISEASES SPREAD THROUGH BLOOD AND BODY FLUIDS

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016

LABOR. PEOSH Revised Bloodborne Pathogens Standard WHAT IS THE REVISED PEOSH BLOODBORNE PATHOGENS STANDARD?

Body Fluid Exposure:

Lancet Device Incident Investigation Report

Blood-borne viruses in the workplace Guidance for employers and employees

Health Care Worker Health and Safety: Preventing Needlestick Injury and Occupational Exposure to Bloodborne Pathogens

Exposure Control Plan Bloodborne Infectious Diseases

MUSC Occupational Blood Borne Pathogen Protocol Off-Campus Procedure Packet

Learning about Hepatitis C and Chronic Kidney Disease

Safe Tattooing How is it done? Things to remember before getting a tattoo: What are the risks? Hepatitis B Hepatitis C: HIV/AIDS:

BLOOD AND BODY FLUID EXPOSURE MANAGEMENT TOOL

Post-Exposure Prophylaxis

Appendix 3 Exposure Incident Report Form

& OSHA STANDARDS TARGET GROUP: Core Campus Nursing Students SECTION: Academic

Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis

This pamphlet describes how all school employees, regardless of job assignment, can minimize the risk of exposure to viral hepatitis.

Risk assessment and needlestick injuries

Training on Standard Operating Procedures for Health Care Waste Management Swaziland 12 May, 2011

University Health Services Health and Safety EXPOSURE CONTROL PLAN

Bloodborne Pathogens Annual Training Module

GUIDE TO FOLLOW UP TESTING FOR BLOOD OR BODY FLUID EXPOSURES AND NEEDLESTICK INJURIES

1.How did I get Hepatitis C?

Adherence to an Occupational Blood Borne Pathogens Exposure Management Program Among Healthcare Workers and Other Groups at Risk in Argentina

Management Plan For Control of Blood-borne Pathogens, Infectious Wastes and Other Potentially Hazardous Biological Agents

INFECTION CONTROL PRECAUTIONS

Are you Hep C aware? awareness information support prevention To find out more visit

Knowledge about Post-exposure Prophylaxis for Hepatitis B Virus among Dentists and Dental Students in Pakistan

Environmental Health and Safety Offices BLOODBORNE PATHOGENS


MARIST COLLEGE. Bloodborne Pathogens Standard (29 CFR )

Blood/Bodily Fluid Exposure and Needlestick Injury Policy Statement & HIV PEP Kit Dispensing Guideline

BLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN

College of Charleston. Bloodborne Pathogen Exposure Control Plan

1.0 Purpose, Applicability, and Scope. 2.0 Abbreviations, Acronyms, and Definitions

Response to Biological Spills in the Laboratory (Intentional or Accidental)

How Does a Doctor Test for AIDS?

DEPARTMENT OF HEALTH AND SENIOR SERVICES PO BOX 360 TRENTON, N.J

Guidelines for Viral Hepatitis CTR Services

Exposure Control Plan

Newly Diagnosed: HEPATITIS C. American Liver Foundation Support Guide

The methods of implementation of these elements of the standard are discussed in the subsequent pages of this ECP.

Patient Information Sheet

Title: Post Exposure Prophylaxis Page 1 of 8 Policy No: 1 CLN 010 Effective Date 04/15/11

POSTEXPOSURE PROPHYLAXIS

OSHA Bloodborne Pathogens Requirements

The Hepatitis B virus (HBV)

BSM Connection elearning Course

Commonly Asked Questions About Chronic Hepatitis C

UNIVERSITY OF KENTUCKY HEALTH CARE COLLEGES POLICY ON EDUCATIONAL EXPOSURE TO BLOOD BORNE PATHOGENS

GUIDELINES FOR THE MANAGEMENT OF A PERCUTANEOUS OR SEXUAL EXPOSURE TO BLOODBORNE PATHOGENS DEPARTMENT OF HEALTH AND WELLNESS PRINCE EDWARD ISLAND

WEST VIRGINIA UNIVERSITY EXPOSURE CONTROL PLAN FOR NON-HOSPITAL PERSONNEL

Transcription:

Bloodborne Pathogens Safety Guidelines

What are bloodborne pathogens? o Bloodborne pathogens are infectious materials in blood, and other body fluids, that can cause disease in humans. o Hepatitis B virus (HBV), Hepatitis C virus (HCV), and the Human Immunodeficiency Virus (HIV) are of primary concern for transmission, for health care workers. (Center for Disease Control and Prevention [CDC], 2010)

Hepatitis B Virus (HBV)

Transmission of HBV Spread by parenteral contact with: o Infected blood o Infected blood products o Contaminated needles o Infected mother to her newborn o Sexual contact. (Copstead & Banasik, 2010; Heymann, 2008)

Incubation of HBV o Usually 45-180 days o Average 60-90 days o Acute infection (lasting a few weeks) o Chronic infection (long term disease that can lead to liver failure or liver cancer). (Copstead & Banasik, 2010; Heymann, 2008)

Diagnosis of HBV o Serologic detection of HBsAG (surface antigen) or o Antibody to HBcAG (core antigen). (Copstead & Banasik, 2010; Heymann, 2008)

Treatment of HBV o Mostly supportive with acute hepatitis o Most non-fulminant infections resolve spontaneously o Approximately 5% of acute infections lead to chronic infections (Copstead & Banasik, 2010; Heymann, 2008)

Prevention of HBV o Vaccination with HBV vaccine given at 0, 1, and 6 months. o After full course of vaccine antibodies are present in 95% of recipients. o Recommended for all health care workers. o Use of personal protective equipment. (Copstead & Banasik, 2010; Heymann, 2008)

Hepatitis C Virus (HCV)

Transmission of HCV Spread primarily parenteral through: o Contaminated blood or blood products o Contaminated needles o Other activities that break the skin (ex. unsterilized equipment, Tattooing, etc). o Sexual and mother to child transmission has been documented, although rare. (Copstead & Banasik, 2010; Heymann, 2008)

Incubation of HCV o 2 weeks- 6months, usually 6-9 weeks. o Chronic infection can be present for up to 20 years before liver disease ensues. o Only 15% of acute infections resolve, the remainder progress to chronic infection which is one of the most common causes of cirrhosis and end-stage liver disease, can also cause liver cancer. (Copstead & Banasik, 2010; Heymann, 2008)

Diagnosis of HCV o Serologic, antibody to HCV (anti-hcv). (Copstead & Banasik, 2010; Heymann, 2008)

Treatment of HCV o Supportive o Can be treated if complications occur (liver failure). o If liver failure ensues can be treated with medications: interferon and ribavirin o Liver transplant can be an option if liver failure ensues (Copstead & Banasik, 2010; Heymann, 2008)

Prevention of HCV o There is no vaccine. o Use of personal protective equipment. (Copstead & Banasik, 2010; Heymann, 2008)

Human Immunodeficiency Virus (HIV)

Transmission of HIV Spread through: o Contaminated blood or blood products o Bodily fluids o Sexual contact o Contaminated needles o Mother to child o Unsterilized equipment o Exposed cuts or scratches to hands (Copstead & Banasik, 2010)

Incubation of HIV o Ranging from 3 weeks to 6 months after exposure o Rarely up to 14 months. (Copstead & Banasik, 2010)

Diagnosis of HIV o Enzyme-linked immunosorbent assay (ELISA)- to detect antibodies to HIV o Western blot- also used to detect antibodies to HIV. o AIDS is a CD4+ count of <200 ul with an opportunistic infection. (Copstead & Banasik, 2010)

Treatment of HIV o Anti-retrovirals o Nucleoside reverse transcriptase inhibitors o Non-nucleopside reverse transcriptase o Protease inhibitors o Fusion inhibitors o CCR5 o Other treatments (Copstead & Banasik, 2010)

Prevention of HIV o There is no vaccine. o Use of personal protective equipment (Copstead & Banasik, 2010)

Health Care worker Statistics

Hepatitis B o Infections that occur in health care industry accounts for 3% of U.S. infections (Copstead & Banasik, 2010, p. 886). o Transmission from a single needle stick risk is approximately 6-30%. (CDC, 2003) o Vaccination almost eliminates risk (Copstead & Banasik, 2010, p. 887; CDC, 2003).

Hepatitis C After a needle stick with an infected needle there is a 1.8% risk of transmission. (CDC, Hepatitis C FAQ s, 2011)

HIV o There has been no documentation of confirmed cases of occupational transmission of HIV since 1999 (CDC, Occupational HIV Transmission, 2011). o Risk of exposure from a single needle stick is approximately 0.3% (Copstead & Banastik, 2010, p. 887).

Prevention o Complete HBV vaccination o Wash your hands before and after contact with patients o Wear disposable gloves when there is a possibility of coming in contact with blood or blood products, anything contaminated by blood, performing an accu check, or a heel stick. o When there is a potential risk of splashes or airborne droplets don gowns, mask, goggles, and face shields. (Copstead & Banasik, 2010, p. 268)

Prevention Continued o Dispose of sharps appropriately (in labeled hospital approved containers) and immediately after use. o Use syringes and needles with safety devices in place and use them as directed o Use Resuscitation bags, no mouth to mouth. (Copstead & Banasik, 2010, p. 268)

If Exposed o Immediately wash needle stick area with soap and water. o Splashes: flush nose, mouth and skin with water. o Irrigate eyes with clean water, sterile saline, or sterile irrigants. o Report incident to immediate supervisor and follow hospital policy and procedure for postexposure. o Begin Treatment if indicated (CDC, 2003)

Post-Exposure Treatment Options

Hepatitis B Post-Exposure Treatment Hepatitis B Immune Globulin (HBIG) alone or with concurrent Hepatitis B vaccination (if not vaccinated). Treatment should occur as soon as possible after exposure, preferably within 24 hours, no later than 7 days. (CDC, 2003)

Hepatitis C Post- Exposure Treatment o There is no vaccine. o There are no treatment recommendations. (CDC, 2003)

HIV Post-Exposure Treatment o Post-exposure prophylaxis (PEP) may be used after a high risk exposure. o PEP should be discussed with physician due to serious side effects of the medications, and should not be used if there is no risk of transmission. o PEP, if used, should be started within 72 hours of exposure and last 4 weeks. (CDC, 2003)

References Center for Disease Control and Prevention. (2003). Exposure to blood: What health care personnel need to know. Retrieved from: http://www.cdc.gov/ncidod/dhqp/pdf/bbp/exp_to_blood.pdf Center for Disease Control and Prevention. (2010). Workplace safety & health: Bloodborne infectious diseases: HIV/AIDS, Hepatitis B, Hepatitis C. Retrieved from: http://www.cdc.gov/niosh/topics/bbp/ Center for Disease Control and Prevention. (2011). Hepatitis C FAQ s for health professionals. Retrieved from: http://www.cdc.gov/hepatitis/hcv/hcvfaq.htm#f1 Center for Disease Control and Prevention. (2011). Occupational HIV transmission and prevention among health care workers. Retrieved from: http://www.cdc.gov/hiv/resources/factsheets/pdf/hcw.pdf Copstead, L. C. & Banasik. (2010). Pathophysiology (4th Ed.). St. Louis, MO: Saunders Elsevier. Heymann, D. L. (2008). Control of communicable diseases manual (19th Ed). Washington, D.C: American Public Health Association